Cargando…

Inspiratory muscle training for recovered COVID-19 patients after weaning from mechanical ventilation: A pilot control clinical study

BACKGROUND. To the best of our knowledge, no studies have evaluated the effects of inspiratory muscle training (IMT) on recovered COVID-19 patients after weaning from mechanical ventilation. Therefore, this study assessed the efficacy of IMT on recovered COVID-19 patients following mechanical ventil...

Descripción completa

Detalles Bibliográficos
Autores principales: Abodonya, Ahmed M., Abdelbasset, Walid Kamal, Awad, Elsayed A., Elalfy, Ibrahim E., Salem, Hosni A., Elsayed, Shereen H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8021337/
https://www.ncbi.nlm.nih.gov/pubmed/33787632
http://dx.doi.org/10.1097/MD.0000000000025339
Descripción
Sumario:BACKGROUND. To the best of our knowledge, no studies have evaluated the effects of inspiratory muscle training (IMT) on recovered COVID-19 patients after weaning from mechanical ventilation. Therefore, this study assessed the efficacy of IMT on recovered COVID-19 patients following mechanical ventilation. METHODS. Forty-two recovered COVID-19 patients (33 men and 9 women) weaned from mechanical ventilation with a mean age of 48.05 ± 8.85 years were enrolled in this pilot control clinical study. Twenty-one patients were equipped to 2-week IMT (IMT group) and 21 matched peers were recruited as a control (control group). Forced vital capacity (FVC%), forced expiratory volume in 1 second (FEV1%), dyspnea severity index (DSI), quality of life (QOL), and six-minute walk test (6-MWT) were assessed initially before starting the study intervention and immediately after intervention. RESULTS. Significant interaction effects were observed in the IMT when compared to control group, FVC% (F = 5.31, P = .041, ηP(2) = 0.13), FEV1% (F = 4.91, P = .043, ηP(2) = 0.12), DSI (F = 4.56, P = .032, ηP(2) = 0.15), QOL (F = 6.14, P = .021, ηP(2) = 0.17), and 6-MWT (F = 9.34, P = .028, ηP(2) = 0.16). Within-group analysis showed a significant improvement in the IMT group (FVC%, P = .047, FEV1%, P = .039, DSI, P = .001, QOL, P < .001, and 6-MWT, P < .001), whereas the control group displayed nonsignificant changes (P > .05). CONCLUSIONS. A 2-week IMT improves pulmonary functions, dyspnea, functional performance, and QOL in recovered intensive care unit (ICU) COVID-19 patients after consecutive weaning from mechanical ventilation. IMT program should be encouraged in the COVID-19 management protocol, specifically with ICU patients.